INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2015
Net Assets |
£222m |
Net Assets per share |
558p |
Share price |
509p |
Total value of unquoted investments |
£20m |
Total number of portfolio companies |
96 |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
8.0 |
Celgene |
8.0 |
Gilead |
7.8 |
Regeneron |
7.8 |
Ophthotech |
4.9 |
Biogen |
4.7 |
Vertex |
4.1 |
Alexion |
4.0 |
Incyte |
3.1 |
Biomarin |
2.9 |
|
----------- |
Total |
55.3 |
Portfolio Profitability |
% NAV |
Profitable |
53 |
Turning Profitable 2015 |
7 |
Unprofitable |
40 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
85 |
Europe & UK |
15 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 NOVEMBER 2015